You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

Article metrics

Article menu
Commentary
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2026

AbstractFullPdf
Nov 202264647
Dec 2022444447244
Jan 202322923256
Feb 202317617649
Mar 202314314551
Apr 202313814044
May 202312012239
Jun 202312012135
Jul 202312312327
Aug 202311211125
Sep 2023989821
Oct 202311611644
Nov 202312312423
Dec 202311611747
Jan 2024585821
Feb 2024808034
Mar 202412212252
Apr 2024575729
May 2024464614
Jun 2024656415
Jul 202410010133
Aug 2024767521
Sep 2024888819
Oct 202411411423
Nov 2024717321
Dec 202410610714
Jan 202510510523
Feb 202512612623
Mar 202510410424
Apr 2025999936
May 2025666621
Jun 2025343413
Jul 2025220
Sep 2025110
Mar 2026110
Total364336591148